Charles Schwab’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.7M Buy
403,485
+23,744
+6% +$525K ﹤0.01% 2218
2025
Q4
$9.18M Buy
379,741
+10,206
+3% +$267K ﹤0.01% 2181
2025
Q3
$9.43M Buy
369,535
+22,553
+6% +$535K ﹤0.01% 2148
2025
Q2
$7.47M Buy
346,982
+6,156
+2% +$139K ﹤0.01% 2150
2025
Q1
$7.78M Sell
340,826
-5,595
-2% -$147K ﹤0.01% 2067
2024
Q4
$8.99M Buy
346,421
+26,462
+8% +$658K ﹤0.01% 2066
2024
Q3
$8.01M Buy
319,959
+9,750
+3% +$230K ﹤0.01% 2140
2024
Q2
$6.65M Buy
310,209
+5,939
+2% +$115K ﹤0.01% 2222
2024
Q1
$5.64M Buy
304,270
+19,146
+7% +$335K ﹤0.01% 2239
2023
Q4
$4.63M Buy
285,124
+3,126
+1% +$39.9K ﹤0.01% 2343
2023
Q3
$3.89M Buy
281,998
+16,754
+6% +$264K ﹤0.01% 2363
2023
Q2
$5.86M Buy
265,244
+7,389
+3% +$156K ﹤0.01% 2175
2023
Q1
$5.61M Buy
257,855
+3,889
+2% +$87.5K ﹤0.01% 2150
2022
Q4
$4.62M Buy
253,966
+5,191
+2% +$107K ﹤0.01% 2252
2022
Q3
$5.66M Buy
248,775
+23,078
+10% +$494K ﹤0.01% 2151
2022
Q2
$3.12M Buy
225,697
+53,425
+31% +$784K ﹤0.01% 2395
2022
Q1
$3.92M Buy
172,272
+6,628
+4% +$174K ﹤0.01% 2387
2021
Q4
$6.17M Sell
165,644
-27,429
-14% -$1.18M ﹤0.01% 2245
2021
Q3
$8.17M Sell
193,073
-10,105
-5% -$487K ﹤0.01% 2129
2021
Q2
$9.04M Buy
203,178
+54,000
+36% +$1.9M ﹤0.01% 2057
2021
Q1
$5.37M Buy
149,178
+5,441
+4% +$215K ﹤0.01% 2266
2020
Q4
$5.73M Buy
143,737
+5,260
+4% +$179K ﹤0.01% 2149
2020
Q3
$4.01M Buy
138,477
+116,108
+519% +$2.51M ﹤0.01% 2185
2020
Q2
$366K Buy
22,369
+3,971
+22% +$54.7K ﹤0.01% 2958
2020
Q1
$175K Hold
18,398
﹤0.01% 3034
2019
Q4
$298K Buy
18,398
+1,402
+8% +$22.8K ﹤0.01% 2973
2019
Q3
$283K Buy
16,996
+307
+2% +$5.76K ﹤0.01% 2981
2019
Q2
$283K Buy
+16,689
New +$291K ﹤0.01% 3035

Other funds holding BLFS